logo

For the Inventor, By the Inventor

Pennington, NJ, United States of America

Edward W Petrillo, Jr

This inventor holds 34 USPTO granted patents, plus 1 CIPO patent, primarily in Phosphorus Compounds. Top assignees: E. R. Squibb Sons, Inc., F. R, Squibb & Sons, Inc.. Active years: 1978-1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edward W Petrillo, Jr. Retrieved from https://idiyas.com/inventor/edward-w-petrillo-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34

% Patents Active = 100.0


Average Co-Inventor Count = 1.7

ph-index = 19

Forward Citations = 1,087(Granted Patents)


Company Filing History:

goldMedal33 out of 1,624 
 
E. R. Squibb Sons, Inc.
 patents
silverMedal1 out of 2 
 
F. R, Squibb & Sons, Inc.
 patents

Years Active: 1978-1989

Loading Chart...
Loading Chart...
Areas of Expertise:
Phosphinic Acids
Renin Inhibitors
Antihypertensives
Phosphonyl Compounds
Amino Acid Derivatives
Phosphonamidate Compounds
Hypotensive Agents
Carboxyalkyl Amino Acids
Substituted Prolines
Mercaptoacyl Compounds
Phosphonoacyl Prolines
Aminoalkyl Compounds
34 patents (USPTO):Explore Patents
1. 4873356 - Method for preparing phosphinic acids used in preparing ace inhibitors (1989-10-10),
2. 4757050 - Ureido renin inhibitors (1988-07-12),
3. 4745196 - Orally active phosphonyl hydroxyacyl prolines (1988-05-17),
4. 4716155 - Phosphorus containing compounds and hypotensive use thereof (1987-12-29),
5. 4703043 - Phosphonyl hydroxyacyl amino acid derivatives as antihypertensive (1987-10-27),
6. 4665193 - Amino acid ester renin inhibitors (1987-05-12),
7. 4629724 - Amino acid ester and amide renin inhibitors (1986-12-16),
8. 4616088 - Amino acid ester and amide renin inhibitor (1986-10-07),
9. 4616005 - Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives (1986-10-07),
10. 4567166 - Amino and substituted amino phosphinylalkanoyl compounds useful for (1986-01-28),
11. 4560680 - Aminoalkyl and related substituted phosphinic acid angiotensin (1985-12-24),
12. 4555506 - Phosphorus containing compounds and use as hypotensives (1985-11-26),
13. 4462943 - Carboxyalkyl amino acid derivatives of various substituted prolines (1984-07-31),
14. 4452791 - Aminoalkyl and related substituted phosphinic acid angiotensin (1984-06-05),
15. 4452790 - Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives (1984-06-05),

Title: Edward W. Petrillo, Jr.: Innovator in Pharmaceutical Chemistry

Introduction

Edward W. Petrillo, Jr., residing in Pennington, NJ, is a noteworthy inventor with a prolific portfolio of 34 patents. His contributions, particularly in the field of pharmaceutical chemistry, have played a significant role in the development of vital medical compounds, especially those aimed at treating hypertension and related conditions.

Latest Patents

Among his most recent innovations are a method for preparing phosphinic acids that are instrumental in synthesizing angiotensin-converting enzyme (ACE) inhibitors. These compounds are valuable in pharmaceutical applications for controlling blood pressure. Additionally, Petrillo has developed ureido renin inhibitors, targeting the conversion of angiotensinogen to angiotensin II, which is crucial in the management of hypertension. These discoveries underline his dedication to enhancing medical treatments through innovative chemical processes.

Career Highlights

Edward W. Petrillo, Jr. has made significant strides in his career, having worked at notable organizations such as E.R. Squibb & Sons, Inc. His experience in these prestigious companies has allowed him to refine his expertise in pharmaceutical sciences and collaborate on groundbreaking projects. His commitment to innovation has resulted in numerous patents that reflect his inventive spirit and technical proficiency.

Collaborations

Throughout his career, Petrillo has had the opportunity to collaborate with talented coworkers such as Donald S. Karanewsky and Denis E. Ryono. These partnerships have fostered an environment of creativity and excellence, driving forward the development of new pharmaceutical compounds and enhancing research outcomes.

Conclusion

Edward W. Petrillo, Jr. stands out as a distinguished inventor whose work has significantly impacted the pharmaceutical industry. With a solid number of patents and a commitment to innovation, he continues to be a prominent figure in the field, pushing boundaries and advancing medical therapies to improve patient outcomes. His legacy is defined by a passion for discovery and a relentless pursuit of excellence in pharmaceutical chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…